Director, National Institute on Drug Abuse National Institute Alcohol

Slides:



Advertisements
Similar presentations
Brookhaven Science Associates U.S. Department of Energy Gene-Jack Wang, M.D. The Addiction-Obesity Connection Brookhaven Science Associates U.S. Department.
Advertisements

Enhancement of auditory fear conditioning after housing in a complex environment is attenuated by prior treatment with amphetamine Lisa A. Briand, Terry.
Stimulant dependence, compulsivity and dopamine TW Robbins CLARE HALL College for Advanced Study BCNI.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes of Health Overlapping Neuronal Circuits In.
DRUG ABUSE & MENTAL ILLNESS: Progress in Understanding COMORBIDITY DRUG ABUSE & MENTAL ILLNESS: Progress in Understanding COMORBIDITY Donald R. Vereen,
Chestnut Health Systems, Normal, IL
Wanting Things How Your Brain Works - Week 8 Dr. Jan Schnupp HowYourBrainWorks.net.
Megan Curran, Stephanie Solso Kevin Nazario, Matt Sugihara.
Women & Addiction: Why is it more difficult for women to quit smoking? Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes.
Social defeat stress, sensitization, and intravenous cocaine self-administration By Jasmine Yap and Klaus Miczek.
Greg L. Jones, MD Medical Director Kentucky Physicians Health Foundation How to Recognize Drug Abuse and Dependence in Patients.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse What Do We Know? Drug Abuse.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse RESEARCH and TREATMENT Provide.
THE BRAIN MODEL OF ADDICTION
SC235 Unit Seven Angela M. Foster, EdD AIM:
Converging and Diverging Neurobiological Features of Feeding and Drug Self- Administration in Humans Dana M Small, PhD Alain Dagher, MD The John B Pierce.
Opiate and Nicotine Addiction: Involvement of cAMP Response Element Binding Protein (CREB) Matt Wolfe
PSYA4 Addictive Behaviour
Neurobiology of drug action and
Examination of Age-Related Cholinergic Activity during Nicotine Exposure and Withdrawal Luis M Carcoba, M.D, Ph.D. University of Texas at El Paso Department.
Bringing the Full Power of Science to Bear on Bringing the Full Power of Science to Bear on NIDA NATIONAL INSTITUTE ON DRUG ABUSE Drug Abuse & Addiction.
Director’s Report to the National Advisory Council on Drug Abuse Director’s Report to the National Advisory Council on Drug Abuse May 22, 2003.
Neurobiology of drug action and addiction Richard Palmiter Dept Biochemistry.
Food and drug cravings: Metaphor or common mechanisms? Marcia Levin Pelchat, Ph.D. Monell Chemical Senses Center May 3, 2004.
Stimulants Methylphenidate (Ritalin, Concerta, Daytrana) Dexmethylphenidate (Focalin) Amphetamine/dextroampheta mine (Adderall) Dextroamphetamine (Dexedrine)
Drug Tolerance Cross Tolerance Metabolic Tolerance
Synaptic plasticity Basic Neuroscience NBL 120. classical conditioning CS (neutral) - no response US - UR After pairing: CS - CR.
Addiction A disease. Facts About Addiction & Treatment WHAT IS ADDICTION? A BRAIN DISEASE BUT WITH BIOLOGICAL, PSYCHOLOGICAL & SOCIAL COMPONENTS DOES.
Intimate Partner Violence & Methamphetamine Claudia J. Wilcox, CADC II Policy & Program Development Specialists April 27, 2007.
Brookhaven Science Associates U.S. Department of Energy Gene-Jack Wang, M.D. Brookhaven Center for Translational Neuroimaging Obesity & Addiction: Neuroimaging.
Lesson 6 Created by Amy Prior Harding University High School.
Chapter 11 Cocaine Amphetamines –Amphetamine –Methamphetamine –Ephedrine –Cathinone – khat –MDMA – ecstasy Methylphenidate Caffeine Nicotine
Addiction: It’s a Brain Disease Beyond a Reasonable Doubt.
© 2012 Cybersex 101. © 2012 A few quotes…INTERNET “…increased availability of the Internet has led some researchers to examine the effects excessive usage.
Copyright © 2009 Allyn & Bacon Chemicals That Harm with Pleasure This multimedia product and its contents are protected under copyright law. The following.
RAMAR  SINCE 1980, RAMAR HAS BEEN A VITAL PART OF RECOVERY FOR CHRONICALLY ADDICTED RECOVERY FOR CHRONICALLY ADDICTED INDIVIDUALS IN NEED IN SUMMIT COUNTY.
Basic Behavioral Neurobiology of Drug Addiction J. David Jentsch, Ph.D. Assistant Professor of Psychology (Behavioral Neuroscience)
Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes of Health Nora D. Volkow, M.D. Director National Institute on Drug Abuse.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse Research Advances in What.
An fMRI Study of the Interaction of Stress and Cocaine Cues on Cocaine Craving in Cocaine-Dependent Men.
Slide 1: The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health and is dedicated to bringing the power of science to.
SC235 Image Credit: Ireland, K. Visualizing Science Wiley & Sons. Unit Seven – Nervous System.
The Neurobiology of Free Will In National Institute on Drug Abuse
Common Brain Mechanisms in ADDICTION Common Brain Mechanisms in ADDICTION Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow,
Central Nervous System Stimulants Constricted Blood Vessels Constricted Blood Vessels Increased Pulse Increased Pulse Increased Blood Pressure Increased.
NICOTINE and the BRAIN Wilson M. Compton, MD, MPE Deputy Director, U.S. National Institute on Drug Abuse.
Advances in science have revolutionized our fundamental views of drug abuse and addiction. Science has come a long way in helping us understand how drugs.
NATIONAL INSTITUTE ON DRUG ABUSE NIDA NIAAA National Institute Alcohol Abuse and Alcoholism Nora D. Volkow, M.D. Director, National Institute on Drug Abuse.
11 Motivation  Nicotine causes DA release in the striatum, part of the mesolimbic DA pathway which mediates reinforcing behaviors (Martin-Soelch et al,
NICOTINE and the BRAIN Wilson M. Compton, MD, MPE Deputy Director, U.S. National Institute on Drug Abuse.
The Science of Addiction. Homelessness Crime Violence Homelessness Crime Violence Neurotoxicity AIDS, Cancer Mental illness Neurotoxicity AIDS, Cancer.
The Reward Pathway And Addiction
بنام خدا DR.KARIMI. DRUG ABUSE & MENTAL ILLNESS: Progress in Understanding COMORBIDITY DRUG ABUSE & MENTAL ILLNESS: Progress in Understanding COMORBIDITY.
Treating DRUG ADDICTION: What Do We Know? What More Should We Do?
Addiction and the human brain
Neurotransmitters: Acetylcholine and Dopamine
Addiction: A Disease of the Brain
Substance Use, Decision Making and the Testing Guidelines
Addiction I’ve never met a person who said they wish they had tried drugs and alcohol sooner…
Motivation Not all responses can be explained by
motivation, reward & addiction
Average for the DV ratio (DVR) images for [11C]raclopride for the controls (n = 20) and the alcoholics (n = 20) at the level of striatum after placebo.
Regression slopes between percentage changes in Bmax′/Kd′ (dependent variable) in VS and absolute regional brain metabolic activity in OFC (BA 11), anterior.
The reward system in addiction
“Say hello to my little neuropeptide”
The Brain on Drugs: From Reward to Addiction
Presentation transcript:

Director, National Institute on Drug Abuse National Institute Alcohol Dopamine’s Role in DRUG CRAVING Nora D. Volkow, M.D. Director, National Institute on Drug Abuse NIDA NIAAA NATIONAL INSTITUTE ON DRUG ABUSE National Institute Alcohol Abuse and Alcoholism

Dopamine Neurotransmission 100 200 300 400 500 600 700 800 900 1000 1100 1 2 3 4 5 hr Time After Amphetamine % of Basal Release AMPHETAMINE Dopamine Neurotransmission VTA/SN nucleus accumbens frontal cortex 50 100 150 200 60 120 180 Time (min) % of Basal Release Empty Box Feeding Di Chiara et al. FOOD

DA and Drug Reinforcement “High” -10 10 20 30 40 -2 2 4 6 8 High (0-10) Change in Dopamine Bmax/kd (Placebo - MP) T Y R O S I N E T Y R O S I N E D O P A D O P A D A D A DA D A DA D A D A D A D A raclopride D A D A D A m e t h y l p n i d a D A D A raclopride D A R R D A D A D A R R R R DA initiates and maintains responses to salient stimuli such as drugs

The mechanism(s) underlying the intense desire for the drug when addicted subjects are exposed to drug cues (places, people and paraphernalia linked with the drug), is still unknown. Since DA is involved with reward and with prediction of reward, it could underlie craving

Background DA Release NAc Auditory cue In rodents when a neutral stimuli is repeatedly paired with the drug (conditioned), it elicits DA increases. In training the cue was paired with cocaine In training the cue was not paired with cocaine Philipps et al Nature 422, 614-618

1. Subjects Eighteen cocaine abusers Inclusion criteria: DSM- IV criteria for cocaine dependence active use for at least the prior 6 months free-base or crack at least "four grams" a week Exclusion criteria: past or present neuro and psychiatric diseases other than cocaine dependence past or present endocrinological disease head trauma with loss of consciousness current medical illness

2. Subjects Gender 17 males, 1 female Age 43 6 years Ethnicity 15 AA, 3 Caucasians Education 13 2 years of education Years used 15 7 years Route 18 smoked cocaine Dose used 2.8 1.6 grams a day Last used 2 1.4 days (range 1 & 6 days) Cigarette smokers 15 current smokers

Methods: Videos The neutral video featured non-repeating segments of nature scenes The cocaine-cue video featured non repeating scenes that simulated purchase, preparation, and smoking of cocaine Videos were shown 10 min prior to radiotracer injection for a total of 40 min

Self-reports of craving during the neutral and the cocaine-cue video Neutral Video Cocaine-Cue Video 2.00 2.50 3.00 3.50 4.00 4.50 5.00 P < 0.01 2.00 2.50 3.00 3.50 4.00 4.50 5.00 Cocaine Craving (1-7) Cocaine Craving Before After Before After Cocaine cues increased self reports of cocaine craving in cocaine abusers Source: Volkow, ND et al., Journal of Neuroscience, 26(24):6583-6588, 2006.

Cue-induced increases in DA were associated with craving Relationship between Cue-Induced Decreases in [11C]raclopride Binding and Cocaine Craving % Change Bmax/Kd -0.50 0.0 0.50 1.0 1.5 2.0 2.5 -40 -30 -20 -10 10 20 30 Putamen Change in Craving (Pre - Post) Caudate P < 0.05 P < 0.002 Cue-induced increases in DA were associated with craving Source: Volkow, ND et al., Journal of Neuroscience, 26(24):6583-6588, 2006.

Craving of Food Why is it that the sight of food can elicit the desire for it even when we are not hungry? Are the responses to cues similar to those that triggered the cocaine in cocaine abusers?

Neutral: Subjects were asked to describe their family genealogy. Ten healthy food deprived controls (15-18 hours food deprivation) tested under neutral and food cue conditions Neutral: Subjects were asked to describe their family genealogy. Food Cues: The food-cue featured non repeating presentation of favorite foods that had been heated to enhance smell Stimuli were presented 10 min prior to radiotracer injection for a total of 40 min

Brain Dopamine Response to Food Stimulation Neutral Food 1.5 2.5 3 3.5 4 -2 2 4 6 8 10 5 15 20 25 30 ml/g (Bmax/Kd) p < 0.005 Desire for Food Placebo/Neutral MP/Food % Change Bmax/kd Source: Volkow, et al., Synapse 2002. p < 0.01

[11C]Raclopride Binding in Food Deprived Controls During Neutral and Food Cues (Bmax/Kd) 2.5 3 3.5 4 Placebo/Neutral MP/Food p < 0.005 1.5 ml/g Neutral Bmax/Kd decreased with exposure to food-cues presumably from DA increases Food Cue Source: Volkow, et al., Synapse 2002.

Relationship Between DA Changes and Self-Reports of Hunger and Desire for Food Induced by Food Cues -2 2 4 6 8 10 5 15 20 25 30 5 10 15 20 25 30 -2 2 4 6 8 Hunger Desire for Food % Change Bmax/kd p < 0.01

Both drug as well as food cues increased DA in dorsal striatum (brain region involved with initiation of action and with learning of habits), suggesting that drugs usurp physiological processes Cue-induced DA increases were associated with craving for drugs as well as for food, which highlights the automated (reflexes) nature of these responses DA activation of DS may underlie the “desire” (wanting) that result in the readiness to engage in the behaviors necessary to procure the desired object whether it’s a drug or food

Funded by DOE and NIH F. Telang, R. MacGregor, P. Carter, D. Schlyer, C. Shea, J. Gatley, S. Dewey, C. Redvanly, P. King L. Caligiuri, G-J Wang, M. Franceschi, Y-S Ding, J. Logan, N. Volkow, J. Fowler, R. Ferrieri, C. Wong (not shown) D. Alexoff, C. Felder, N. Pappas, D. Franceschi, N. Netusil, V. Garza, R. Carciello, D. Warner, M. Gerasimov